Trial for MicroPort's Firesorb BVS: FUTURE-III
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1200 participants.
Also called NCT03660202
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,200 participants
- Registry
-
NCT03660202
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03660202. Allocation not applicable; no masking; primary purpose treatment. Start 2019-01 (anticipated); primary completion 2020-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trial for MicroPort's Firesorb BVS: FUTURE-III
- Acronym
- FUTURE-III
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Firesorb
- Lead sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
Record details
- Record id
cardio:ct-nct03660202- Content hash
20e8b203de059a6269de300c112c1d1454add6f1cd2b468f7a56b24a700269f9